Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial
Tze‐Fan Chao(National Yang Ming Chiao Tung University), Robert P. Giugliano(Thrombolysis in Myocardial Infarction Study Group), Elliott M. Antman(Brigham and Women's Hospital), Rose A. Hamershock(Brigham and Women's Hospital), Eugene Braunwald(Mass General Brigham), Michele Mercuri(Inserm), Shih‐Ann Chen(National Yang Ming Chiao Tung University), Christian T. Ruff(Brigham and Women's Hospital)
Cited by 106
Related Papers
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
|New England Journal of Medicine|2017|6k
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2013|5.1k
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
|New England Journal of Medicine|2015|2k